Researchers have also identified increased levels of miR-494 in DDD murine models, whereas inhibitors of miR-494 led to increased Bcl-2 and neuro-oncological ventral antigen 1 (NOVA1) levels and reduced expression of caspase-3 and Bax [57]. The gene discussed is NOVA1; the disease is Dowling-Degos disease 1.